| DESCRIPTION |
VASQIP Definition (2014):
[preferably cardiac troponin (cTn)] with at least one value above
the 99th percentile Upper Reference Limit (URL) AND at least one
of the following:
a. Symptoms suggestive of myocardial ischemia
b. New or presumed new significant ST-segment-T wave (ST-T) changes
c. New left bundle branch block (LBBB).
d. Development of pathological Q waves in the ECG
e. Imaging evidence of new loss of viable myocardium
f. New regional wall motion abnormality
g. Identification of an intracoronary thrombus by angiography or
Indicate the presence of a peri-operative MI that occurs either
autopsy
2. Cardiac death with symptoms suggestive of myocardial ischemia and
presumed new ischemic ECG changes or new LBBB, but death occurred
before cardiac biomarkers were obtained, or before cardiac
biomarker values would be increased.
3. Percutaneous coronary intervention (PCI) related MI is arbitrarily
defined by elevation of cTn values (>5x 99th percentile URL) in
patients with normal baseline values (<99th percentile URL) or a
rise of cTn values >20% if the baseline values are elevated and
intraoperatively or postoperatively within 30 days: The term acute
are stable or falling,
AND at least one of the following:
a. Symptoms suggestive of myocardial ischemia
b. Presumed new ischemic ECG changes
c. Angiographic findings consistent with a procedural complication
d. Imaging evidence of new loss of viable myocardium
e. New regional wall motion abnormality
4. Stent thrombosis associated with MI when detected by coronary
angiography or autopsy in the setting of myocardial ischemia and
MI should be used when there is evidence of myocardial necrosis in a
with a rise and/or fall of cardiac biomarker values with at least
one value above the 99th percentile URL.
5. Coronary artery bypass grafting (CABG) related MI is arbitrarily
defined by elevation of cardiac biomarker values (>10x 99th
percentile URL) in patients with normal baseline cTn values
(<99th percentile URL),
AND at least one of the following
a. Development of pathological Q waves in the ECG
b. New LBBB
clinical setting consistent with acute myocardial ischemia. Under
c. Angiographic documented new graft or new native coronary
artery occlusion
d. Imaging evidence of new loss of viable myocardium
e. New regional wall motion abnormality
these conditions any ONE of the following criteria meets the diagnosis
for MI:
1. Detection of a rise and/or fall of cardiac biomarker values
|
